LIVE
GBR The Guardian Business EN

Idris Elba-backed firm Huel bought by Danone in €1bn deal

Founder Julian Hearn, actor and fellow investor Jonathan Ross likely to get big payday after takeover by French groupBusiness live – latest updatesHuel, the protein shake maker which counts actor Idris Elba and TV presenter Jonathan Ross among its investors, has agreed to be acquired by the French consumer goods group Danone in a deal worth about €1bn (£870m).The British company, which makes food powders, snack bars and meals from a blend of plant-based ingredients and fortified with vitamins, started out selling its powders online. It is now available in more than 25,000 stores around the world. Continue reading...

Mar 23, 2026 &03562323202631; 10:56 UTC www.theguardian.com Trending 3/5
Read original on www.theguardian.com ↗
Neutral impact
Sentiment score: +15/100
Moderate impact Short-term (days)
WHAT THIS MEANS
Danone has agreed to acquire Huel, a British plant-based nutrition company, for approximately €1 billion. The deal represents Danone's strategic expansion into the high-growth functional nutrition segment, with Huel's founder Julian Hearn and celebrity investors Idris Elba and Jonathan Ross set to benefit from the transaction.
AI CONFIDENCE
72% High
SENTIMENT GAUGE
NEWS POWER SCORE
AFFECTED ASSETS
DANONE.PA
DANONE.PAStock
High volatility expected
€1bn acquisition signals strategic pivot to functional nutrition but requires capital deployment and integration execution; market may view positively (growth strategy) or negatively (valuation, debt impact) depending on investor sentiment toward M&A in current macro environment
Euro Stoxx 50
^STOXX50EIndex
High volatility expected
Danone is a major STOXX 50 constituent; acquisition news creates short-term volatility but broader index impact minimal given diversification
Euro / US Dollar
EURUSDCurrency
High volatility expected
Large euro-denominated M&A transaction may create minor currency flows but unlikely to move major pairs significantly
PRICE HISTORY
Loading chart...
SUGGESTED ACTION
Monitor Danone's earnings guidance and debt levels post-announcement; the deal is strategically sound but valuation appears premium for a private company in uncertain consumer spending environment. Watch for integration execution risks over next 12-24 months. No immediate trading catalyst; treat as neutral corporate development news.
KEY SIGNALS
Large M&A in functional nutrition space signals consolidation trendDanone's strategic bet on plant-based/health-focused productsCelebrity backing (Idris Elba, Jonathan Ross) indicates brand strength but not financial substanceGlobal distribution (25,000+ stores) validates market traction€1bn valuation in current market conditions warrants scrutiny on overpayment risk
SECTORS INVOLVED
Consumer GoodsFood & BeverageFunctional NutritionPlant-Based Foods
Analysis generated on Mar 23, 2026 at 11:19 UTC
Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by The Guardian Business. Always conduct your own research and consult a qualified financial advisor before making investment decisions.